Sort
21,453 grants matching “tuberculosis”
Sequencing Core
$236,961Gregory Seumois · La Jolla Institute For Immunology · U19 · FY2016 · AI
HIV-1 regulation by MTb: pathogen and host factor
$236,750Immune Disease Institute, Inc. · R01 · FY2005 · AI
Minority Health & Health Disparities International Research Training Program
$236,652Robert S Pozos · San Diego State University · T37 · FY2008 · MD
Bioinformatics Software for Analyzing Microbial Genomes
$236,609Steven L. Salzberg · Johns Hopkins University · R01 · FY2011 · GM
Novel IL-17 producing memory cells are key to vaccine-based immunity in the lung
$236,591Shabaana A. Khader · University Of Pittsburgh At Pittsburgh · R00 · FY2009 · AI
Targeting protein-protein interactions as drug targets
$236,563Michael D Burkart · University Of California, San Diego · R21 · FY2021 · AI
International Core
$236,526Robert Gross · University Of Pennsylvania · P30 · FY2022 · AI
Rapid Diagnosis of Pediatric Tuberculosis
$236,525Harshini Mukundan · Los Alamos Nat Secty-Los Alamos Nat Lab · R21 · FY2018 · AI
CD8+ T CELL RESPONSE IN RESISTANCE TO TUBERCULOSIS
$236,351Public Health Research Institute · R01 · FY2000 · HL
CD8+ T CELL RESPONSE IN RESISTANCE TO TUBERCULOSIS
$236,351Public Health Research Institute · R01 · FY2001 · HL
Repurposing Mycobacterium tuberculosis tRNase toxins for cancer chemotherapy
$236,333Nancy Ann Woychik · Rbhs-Robert Wood Johnson Medical School · R21 · FY2022 · CA
Synthesis of natural product scaffold selectively active against dormant Mycobacterium tuberculosis
$236,325Steven Sucheck · University Of Toledo · R21 · FY2018 · AI
Adaptation and testing of a novel text-based tobacco cessation and education intervention in Kenyan Emergency Department patients
$236,288Christine Ngaruiya · Yale University · R21 · FY2021 · DA
Third Generation Antiopportunistic Agents
$236,285Duquesne University · R01 · FY2002 · AI
Immune-mediated elimination of antigen-specific Tregs during infection and cancer
$236,267Kevin B Urdahl · Seattle Biomedical Research Institute · R21 · FY2014 · AI
GENETIC VACCINE FOR MYCOBACTERIUM TUBERCULOSIS
$236,255University Of Texas Sw Med Ctr/Dallas · R01 · FY2000 · AI
Cholesterol oxidation products in TB pathogenesis and as biomarkers of disease
$236,250Jennifer A Philips · Washington University · R21 · FY2021 · AI
Surface dependent inhibition of Mycobacterium abscessus by Pseudomonas aeruginosa
$236,250Daniel J Wozniak · Ohio State University · R21 · FY2024 · AI
Identification by High Throughput Screening of Inhibitors of the Mycobacterium tuberculosis ESX-1 and ESX-5 Type VII Secretion Systems â critical virulence determinants and novel drug targets
$236,250Marcus Aaron Horwitz · University Of California Los Angeles · R21 · FY2025 · AI
Role of Aging on cardiac macrophage dysfunction and heart failure during infection
$236,250Murugesan Rajaram · Ohio State University · R21 · FY2022 · AG
Parallel Microscopic Determination of Fitness (PMDF) to Assess Growth and Viability of Mycobacterium tuberculosis
$236,250David R Sherman · Seattle Biomedical Research Institute · R21 · FY2016 · AI
The Role of SLAMF1 in TB Immunity
$236,188Jennifer A Philips · Washington University · R21 · FY2020 · AI
Characterization of the Abundant Small Proteome of Mycobacteria
$236,170Keith M Derbyshire · Wadsworth Center · R21 · FY2015 · AI
Coenzyme F420-dependent enzymes in mycobacteria
$236,148Biswarup Mukhopadhyay · Virginia Polytechnic Inst And St Univ · R21 · FY2012 · AI
Targetting InhA For Anti-TB Drug Discovery
$236,122Peter J Tonge · State University New York Stony Brook · R01 · FY2006 · AI